No Detail Found!

Brucella-Host Interactions in Cattle: Zoonotic Transmission, Immunological Insights and Non- Antibiotic Strategies

Author(s)
Khalil Mohamed Department of Epidemiology and Medical Statistics, Faculty of Public Health and Health Informatics, Umm Al-Qura University,,Saudi Arabia
Abstract
Bovine brucellosis, caused by Brucella species, is a highly contagious disease of veterinary and medical importance. It poses significant effects on cattle health, reduces productivity, and poses serious threats to public health. The peculiar characteristic of Brucella to survive within the host cells and its ability to evade the immune responses cause major challenges in diagnosis, treatment, and control. Moreover, the zoonotic nature of Brucella is due to the close interaction among livestock animals and humans, especially those who work in proximity to the animals, such as veterinarians and farmers. Various antibiotics have been used over the years to treat brucellosis, but due to their frequent use, scientists have diverted their attention towards more suitable, eco-friendly, sustainable, and immunomodulatory non-antibiotic alternatives such as vaccines, phytochemicals, nanoparticles, probiotics, and most importantly, phage therapy. Vaccines stimulate host immune response and produce antibodies, while phytochemicals and nanoparticles, because of their active chemical constituents, have direct antibacterial effects against Brucella. Similarly, phage therapy causes precise lysis of Brucella while probiotics and prebiotics improve gut microbiota and reduce the burden of pathogens. Finally, the review article highlights future directions, including the use of advanced vaccines, omics-based diagnostics, and artificial intelligence-based systems to increase control measures and decrease zoonotic transmission
Publication Details
Page(s) 527-535
Published Journal: Pakistan Veterinary Journal, Volume: 45, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
Alternatives Antibiotics Brucella Cattle Control Immune response Non-antibiotic treatment
References
Alavi M,Nokhodchi A .2023 .Micro- and nanoformulations of antibiotics against Brucella. Drug Discov Today, 28 : 103809.
Ali S,Nawaz Z,Akhtar A .2018 .Epidemiological investigation of human brucellosis in Pakistan. Jundish J Microb, 11(7) : 1-5.
Ali S,Alsayeqh AF .2022 .Review of major meat-borne zoonotic bacterial pathogens. Front Pub Heal, 10 : 1045599.
Alonso Paiva IM,Santos RA,Brito CB .2023 .Role of the cGAS/STING pathway in the control of Brucella abortus infection acquired through the respiratory route. Front Immunol, 14 : 1116811.
Aruna GL,Pt B .2023 .Development and diagnostic evaluation of indirect enzyme linked immunosorbent assay for Epidermophyton floccosum infection in humans. Int Immunopharmacol, 110910 : .
Bhatwalkar SB,Mondal R,Krishna SBN .2021 .Antibacterial properties of organosulfur compounds of garlic (Allium sativum). Front Microbiol, 12 : 613077.
Bruna T,Maldonado-Bravo F,Jara P .2021 .Silver nanoparticles and their antibacterial applications. Int J Mol Sci, 22 : 7202.
Chauhan RS,Malik YS,Saminathan M .2024 .Immunopathology of reproductive disorders of animals. In: Essentials of Veterinary Immunology and Immunopathology, : 293-372.
Ciesielska A,Matyjek M,Kwiatkowska K .2021 .TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci, 78 : 1233-1261.
Dahiya D,Nigam PS .2023 .Antibiotic-therapy-induced gut dysbiosis affecting gut microbiota-brain axis and cognition: Restoration by intake of probiotics and synbiotics. Int J Mol Sci, 24 : 3074.
Deka RP,Shome R,Dohoo I .2021 .Seroprevalence and risk factors of Brucella infection in dairy animals in urban and rural areas of Bihar and Assam. India. Microorganisms, 9 : 783.
Elbehiry A,Aldubaib M,Marzouk E .2023 .The development of diagnostic and vaccine strategies for early detection and control of human brucellosis, particularly in endemic areas. Vaccines, 11 : 654.
Elrashedy A,Gaafar M,Mousa W .2022 .Immune response and recent advances in diagnosis and control of brucellosis. Ger J Vet Res, 2 : 10-24.
Emencheta SC,Olovo CV,Eze OC .2023 .The role of bacteriophages in the gut microbiota: Implications for human health. Pharmaceutics, 15 : 2416.
Esmaeili S,Amiri FB,Mokhayeri H .2019 .Seroepidemiological study of Q fever, brucellosis and tularemia in butchers and slaughterhouses workers in Lorestan, western of Iran. Comp Immunol Microbiol Infect Dis, 66 : 101322.
Faliti CE,Mesina M,Choi J .2024 .-secreting T helper cells promote extra-follicular B cell maturation via intrinsic regulation of a B cell mTOR-AKT-Blimp-1 axis. Immunity, 57 : 2772-2789.
Fayazi M,Rostami M,Amiri Moghaddam M .2024 .A state-of-theart review of the recent advances in drug delivery systems for different therapeutic agents in periodontitis. J Drug Target, 1 : .
Fernández AG,Hielpos MS,Ferrero MC .2017 .Proinflammatory response of canine trophoblasts to Brucella canis infection. PLoS One, 12 : e0186561.
Fu YY,Ren CE,Qiao PY .2021 .Uterine natural killer cells and recurrent spontaneous abortion. Am J Reprod Immunol, 86 : e13433.
Fuloria S,Mehta J,Chandel A .2022 .A comprehensive review on the therapeutic potential of Curcuma longa Linn. in relation to its major active constituent curcumin. Front Pharmacol, 13 : 820806.
Głowacka P,Żakowska D,Naylor K .2018 .Brucella-virulence factors, pathogenesis and treatment. Pol J Microbiol, 67 : 151.
Hecker YP,González-Ortega S,Cano S .2023 .Bovine infectious abortion: A systematic review and meta-analysis. Front Vet Sci, 10 : 1249410.
Hedges JF,Snyder DT,Robison A .2023 .A TLR4 agonist liposome formulation effectively stimulates innate immunity and enhances protection from bacterial infection. Innate Immun, 29 : 45-57.
Heidary M,Dashtbin S,Ghanavati R .2022 .Evaluation of brucellosis vaccines: A comprehensive review. Front Vet Sci, 9 : 925773.
Hemdan M,Ali MA,Doghish AS .2024 .Innovations in biosensor technologies for healthcare diagnostics and therapeutic drug monitoring: Applications, recent progress, and future research challenges. Sensors (Basel), 24 : 5143.
Hernández-Giottonini KY,Arellano-Reynoso B,Rodríguez-Córdova RJ .2023 .Enhancing therapeutic efficacy against Brucella canis infection in a murine model using rifampicin-loaded PLGA nanoparticles. ACS Omega, 8 : 49362-49371.
Hosseini SM,Farmany A,Alikhani MY .2022 .Co-delivery of doxycycline and hydroxychloroquine using CdTe-labeled solid lipid nanoparticles for treatment of acute and chronic brucellosis. Front Chem, 10 : 890252.
Huy TXN,Nguyen TT,Kim H .2003 .Brucella phagocytosis mediated by pathogen-host interactions and their intracellular survival. Microorganisms, 10 : .
Jiao H,Zhou Z,Li B .2021 .The mechanism of facultative intracellular parasitism of Brucella. Int J Mol Sci, 22 : 3673.
Kaleem M,Durani AZ,Safdar M .2024 .Bovine brucellosis: Exploring the role of phytonutrients in treating the disease. Comp Clin Pathol, 33 : 897-903.
Kar SK,Wells JM,Ellen ED .2021 .Organoids: A promising new in vitro platform in livestock and veterinary research. Vet Res, 52 : 1-17.
Kaur H,Ghorai SM .2022 .Role of cytokines as immunomodulators. In: Immunomodulators and Human Health, : 371-414.
Khatun MM,Islam MA,Baek BK .2021 .In vitro and in vivo IFN-γ and IL-10 measurement in experimental Brucella abortus biotype 1 infection in Sprague-Dawley rats. Vector Borne Zoonotic Dis, 21 : 579-585.
Khoshnood S,Pakzad R,Koupaei M .2022 .Prevalence, diagnosis, and manifestations of brucellosis: A systematic review and metaanalysis. Front Vet Sci, 9 : 976215.
Khurana SK,Sehrawat A,Tiwari R .2021 .Bovine brucellosis-a comprehensive review. Vet Q, 41 : 61-88.
Kumar R,Banerjee S,Akshita S .2024 .Nanotherapeutics for bacterial livestock diseases. In: Nanotechnology Theranostics in Livestock Diseases and Management, : 425-466.
Leprince A,Mahillon J .2023 .Phage adsorption to gram-positive bacteria. Viruses, 15 : 196.
Lueth P,Haughney SL,Binnebose AM .2019 .Nanotherapeutic provides dose sparing and improved antimicrobial activity against Brucella melitensis infections. J Control Release, 294 : 288-297.
Marchesini MI,Spera JM,Comerci DJ JM .2024 .The 'ins and outs' of Brucella intracellular journey. Curr Opin Microbiol, 78 : 102427.
Masadeh MM,Bany-Ali NM,Khanfar MS .2025 .Synergistic antibacterial effect of ZnO nanoparticles and antibiotics against multidrug-resistant biofilm bacteria. Curr Drug Deliv, 22 : 92-106.
Maurizio E,Trangoni MD,Rossi UA .2021 .Characterization of innate immune response to Brucella melitensis infection in goats with permissive or restrictive phenotype for Brucella intramacrophagic growth. Vet Immunol Immunopathol, 234 : 110223.
Modise-Tlotleng BM,Mpoloka SW,Settypalli TBK .2024 .Molecular testing of zoonotic bacteria in cattle, sheep, and goat abortion cases in Botswana. Microorganisms, 12 : 2644.
Mol JPS,Costa EA,Carvalho AF .2014 .Early transcriptional responses of bovine chorioallantoic membrane explants to wild type, ΔvirB2 or ΔbtpB Brucella abortus infection. PLoS One, 9 : e108606.
Monteiro PLJ,Wiltbank MC,Frizzarini WS .2024 .Hormonal profiles and biomarkers leading to parturition in cattle. Biol Reprod, 111 : 1282-1296.
Muhammad I,Niaz S,Gul EN .2021 .Molecular docking and in vitro analysis of Fagonia cretica and Berberis lyceum extracts against Brucella melitensis. Curr Comput Aided Drug Des, 17 : 946-956.
Naseer A,Mo S,Olsen SC,McCluskey B .2023 .Brucella melitensis vaccines: A systematic review. Agriculture, 13 : 2137.
Ogwuche CE,Tomilola A,Hamza B .2025 .Studies on essential oil extracted from Hippocratea velutina leaves in relation to chemical composition, antioxidant and antimicrobial activities. , : 28-33.
Oliveira SC .2021 .Host immune responses and pathogenesis to Brucella spp. infection. Pathogen, 10(3) : 288.
Ötkün S,Gürbilek SE,Saytekin AM .2023 .The isolation and examination of the host specificity of local bacteriophages for use against Brucella abortus. Harran Univ Vet Fak Derg, 12 : 80-85.
Pal N,Sharma P,Kumawat M .2024 .Phage therapy: An alternative treatment modality for MDR bacterial infections. Infect Dis, 56 : 785-817.
Palankar R,Sachs L,Wesche J .2022 .Cytoskeleton dependent mobility dynamics of FcγRIIA facilitates platelet haptotaxis and capture of opsonized bacteria. Cells, 11 : 1615.
Pascual DW,Goodwin ZI,Bhagyaraj E .2022 .Activation of mucosal immunity as a novel therapeutic strategy for combating brucellosis. Front Microbiol, 13 : 1018165.
Pellegrini JM,Gorvel JP,Mémet S .2022 .Immunosuppressive mechanisms in brucellosis in light of chronic bacterial diseases. Microorganisms, 10 : 1260.
Pérez RO,Mata RA,Domínguez GA .2024 .Retrospective brucellosis study in Mexico. Int J Vet Med, 3 : 1-6.
Polo C,García-Seco T,Díez-Guerrier A .2023 .What about the bull? A systematic review about the role of males in bovine infectious infertility within cattle herds. Vet Anim Sci, 19 : 100284.
Priyanka ,Shringi BN,Choudhary OP .2021 .Cytokines in brucellosis: Biological rhythm at the interface of innate and adaptive immunity. Biol Rhythm Res, 52 : 1031-1043.
Qureshi KA,Parvez A,Fahmy NA .2023 .Brucellosis: Epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review. Ann Med, 55 : 2295398.
Rahman MZ,Islam MA,Bose P .2024 .Immune response and protective efficacy of an experimentally developed inactivated oil adjuvant Brucella abortus vaccine in BALB/c mice. J Adv Vet Anim Res, 11 : 914.
Rainard P,Foucras G,Martins RP .2022 .Adaptive cell-mediated immunity in the mammary gland of dairy ruminants. Front Vet Sci, 9 : 854890.
Roop RM,Barton IS,Hopersberger D .2021 .Uncovering the hidden credentials of Brucella virulence. Microbiol Mol Biol Rev, 85 : 10-1128.
Rungue M,Melo V,Martins D .2021 .-associated host microbiota composition impacts in the intestinal barrier to systemic dissemination of Brucella abortus. PLoS Neg Trop Dis, 15 : e0009171.
Sadeghi Z,Fasihi-Ramandi M,Bouzari S .2020 .Nanoparticle-based vaccines for brucellosis: calcium phosphate nanoparticles-adsorbed antigens induce cross protective response in mice. Int J Nanomed, : 3877-3886.
Sancho E,Granados-Chinchilla F,Barquero-Calvo E .2022 .Determination of streptomycin and doxycycline using LC/MS towards an effective treatment against an experimental Brucella abortus infection in mice. J Microbiol Methods, 194 : 106436.
Saxena HM .2021 .Brucellosis: the second most important, yet neglected, zoonotic disease. World J Vet Sci, 9 : 40-49.
Shahid A,Ali MA,Muzammil S .2021 .Antibiotic residues in food chains; impact on the environment and human health: a review. Appl Ecol Environ Res, 19 : 3959-3977.
Shahrabi AR,Moradkasani S,Goodarzi F .2023 .Prevalence of Brucella melitensis and Brucella abortus tetracyclines resistance: a systematic review and meta-analysis. Microb Pathog, 183 : 106321.
Staroverov SA .2024 .The immunostimulatory roles of gold nanoparticles in immunization and vaccination against Brucella abortus antigens. Int Immunopharmacol, 133 : 112121.
Suwannawong N,Thumarat U,Phongphanich P .2022 .Association of natural resistance-associated macrophage protein 1 polymorphisms with Salmonella fecal shedding and hematological traits in pigs. Vet World, 15 : 2738.
Goshisht Tripathi N,MK Tripathi N .2022 .Recent advances and mechanistic insights into antibacterial activity, antibiofilm activity and cytotoxicity of silver nanoparticles. ACS Appl Bio Mater, 5 : 1391-1463.
Tulu D .2022 .Bovine brucellosis: epidemiology, public health implications, and status of brucellosis in Ethiopia. Vet Med Res Rep, : 21-30.
Tyler CJ,Hoti I,Griffiths DD .2024 .21 conditions antigenpresenting human γδ T-cells to promote IL-10 expression in naïve and memory CD4+ T-cells. Discov Immunol, 3 : kyae008.
Udainiya S,Tiwari A,Singh B .2025 .Infectious abortive diseases: brucellosis. In: Elements of Reproduction and Reproductive Diseases of Goats, : 307-318.
Wang M,Zhang J,Wei J .2024 .Phage-inspired strategies to combat antibacterial resistance. Crit Rev Microbiol, 50 : 196-211.
Whatmore AM,Foster JT .2021 .Emerging diversity and ongoing expansion of the genus Brucella. Infect Genet Evol, 92 : 104865.
Wicherska-Pawłowska K,Wróbel T,Rybka J .2021 .RLRs ligands as immunotherapeutic agents for hematopoietic diseases. Int J Mol Sci, 22 : 13397.
Wu L,Zhang G,Dang S .2023 .Application of immunomodulatory therapy in a human brucellosis patient with pancytopenia: a case report. Heliyon, 9 : e18907.
Xiao Y,Li M,Guo X .2022 .Inflammatory mechanism of Brucella infection in placental trophoblast cells. Int J Mol Sci, 23 : 13417.
Xu Z,Tong Z,Zhang H .2024 .Effects of major OMPs and LPS of Brucella on the control of activation of bone marrow-derived dendritic cells and proliferation of T-lymphocytes in mice. Iran J Vet Res, 25 : 224.
Yanti Y,Sumiarto B,Kusumastuti TA .2021 .Seroprevalence and risk factors of brucellosis and the brucellosis model at the individual level of dairy cattle in the West Bandung District, Indonesia. Vet World, 14(1) : 1-10.
Yarahmadi A,Najafiyan H,Yousefi MH .2025 .Beyond antibiotics: exploring multifaceted approaches to combat bacterial resistance in the modern era: a comprehensive review. Front Cell Infect Microbiol, 15 : 1493915.
Yu H,Gu X,Wang D .2024 .Brucella infection and Toll-like receptors. Front Cell Infect Microbiol, 14 : 1342684.
Yu J,Li S,Wang L .2022 .Pathogenesis of Brucella epididymoorchitis-game of Brucella death. Crit Rev Microbiol, 48 : 96-120.
Zamani N,Ganjy Z,Sharif MR .2022 .The effects of probiotics supplementation on clinical status and biomarkers of oxidative damage and inflammation in children with brucellosis: a randomized, double‐blind, and placebo‐controlled trial. Evid Based Complement Alternat Med, : 2541117.
Zenu F,Bekele T .2024 .Major food-borne zoonotic bacterial pathogens of livestock origin: a review. Foods Raw Mater, 12 : 179-193.
Zhao T,Zhang Z,Li Y .2023 .Brucella abortus modulates macrophage polarization and inflammatory response by targeting glutaminases through the NF-κB signaling pathway. Front Immunol, 14 : 1180837.
0

Citations

0

Downloads

78

Views